Edgewise Therapeutics Cash from Financing (TTM) Analysis

Edgewise Therapeutics Inc (EWTX)

17.55 +0.08 (+0.46%) USD | NASDAQ | Sep 06, 16:00

17.54 -0.01 (-0.06%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
June 30, 2024	295.80M
March 31, 2024	294.22M
December 31, 2023	53.17M
September 30, 2023	-0.124M
June 30, 2023	129.78M
March 31, 2023	129.59M
December 31, 2022	129.64M
September 30, 2022	130.24M

Date	Value
June 30, 2022	0.582M
March 31, 2022	-0.493M
December 31, 2021	186.38M
September 30, 2021	281.09M
June 30, 2021	306.20M
March 31, 2021	307.23M
December 31, 2020	120.28M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.493M

Minimum

Mar 2022

307.23M

Maximum

Mar 2021

157.57M

Average

129.78M

Median

Jun 2023

Cash from Financing (TTM) Benchmarks